S. Giraudi

1.2k total citations
24 papers, 716 citations indexed

About

S. Giraudi is a scholar working on Public Health, Environmental and Occupational Health, Oncology and Reproductive Medicine. According to data from OpenAlex, S. Giraudi has authored 24 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Public Health, Environmental and Occupational Health, 12 papers in Oncology and 7 papers in Reproductive Medicine. Recurrent topics in S. Giraudi's work include Reproductive Biology and Fertility (12 papers), Cancer Risks and Factors (9 papers) and Estrogen and related hormone effects (6 papers). S. Giraudi is often cited by papers focused on Reproductive Biology and Fertility (12 papers), Cancer Risks and Factors (9 papers) and Estrogen and related hormone effects (6 papers). S. Giraudi collaborates with scholars based in Italy, Belgium and United Kingdom. S. Giraudi's co-authors include Alessia Levaggi, Lucia Del Mastro, P. Pronzato, Claudia Bighin, Matteo Lambertini, Stefania Gori, Teresa Gamucci, Monica Giordano, Luca Boni and Ornella Garrone and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and British Journal of Cancer.

In The Last Decade

S. Giraudi

24 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Giraudi Italy	11	548	470	278	129	111	24	716
Hatem A. Azim Italy	7	296 0.5×	171 0.4×	329 1.2×	70 0.5×	126 1.1×	14	538
Luca Arecco Italy	15	224 0.4×	157 0.3×	280 1.0×	84 0.7×	61 0.5×	48	516
Emanuela Magnolfi Italy	6	248 0.5×	207 0.4×	176 0.6×	62 0.5×	47 0.4×	12	366
Eva Blondeaux Italy	13	205 0.4×	151 0.3×	272 1.0×	60 0.5×	94 0.8×	58	500
Thea M. Mooij Netherlands	10	239 0.4×	469 1.0×	101 0.4×	62 0.5×	268 2.4×	21	725
Alessia D’Alonzo Italy	9	175 0.3×	149 0.3×	136 0.5×	61 0.5×	36 0.3×	23	341
Amiram Fishman Israel	13	107 0.2×	273 0.6×	119 0.4×	120 0.9×	229 2.1×	17	622
Michelle Vaughan New Zealand	8	96 0.2×	299 0.6×	165 0.6×	95 0.7×	33 0.3×	16	490
Hanne Stensheim Norway	8	172 0.3×	110 0.2×	574 2.1×	68 0.5×	32 0.3×	12	682
Alessia Romito Italy	11	78 0.1×	209 0.4×	118 0.4×	98 0.8×	30 0.3×	19	394

Countries citing papers authored by S. Giraudi

Since Specialization

Citations

This map shows the geographic impact of S. Giraudi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Giraudi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Giraudi more than expected).

Fields of papers citing papers by S. Giraudi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Giraudi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Giraudi. The network helps show where S. Giraudi may publish in the future.

Co-authorship network of co-authors of S. Giraudi

This figure shows the co-authorship network connecting the top 25 collaborators of S. Giraudi. A scholar is included among the top collaborators of S. Giraudi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Giraudi. S. Giraudi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Molinelli, Chiara, Lucia Del Mastro, S. Giraudi, et al.. (2020). 226P Impact of BMI on outcome and cardiac safety in HER2-positive breast cancer patients treated with adjuvant trastuzumab: Results of a monocentric observational study. Annals of Oncology. 31. S331–S331. 1 indexed citations

Bighin, Claudia, Béatrice Dozin, Francesca Poggio, et al.. (2017). Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: results of an observational study. Oncotarget. 8(27). 44800–44810. 4 indexed citations

Poggio, Francesca, Marcello Ceppi, Matteo Lambertini, et al.. (2017). Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis. The Breast. 33. 104–108. 17 indexed citations

Lambertini, Matteo, Paola Anserini, Valeria Fontana, et al.. (2017). The PREgnancy and FERtility (PREFER) study: an Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients. BMC Cancer. 17(1). 346–346. 30 indexed citations

Giraudi, S., Andrea Michelotti, Andrea De Censi, et al.. (2016). Dose-dence adjuvant chemotherapy in early breast cancer: the results of 15 years of follow-up. Annals of Oncology. 27. iv61–iv61. 1 indexed citations

Blondeaux, Eva, Paolo Bruzzi, Matteo Lambertini, et al.. (2016). Treatment with aromatase inhibitors and markers of cardiovascular disease. Breast Cancer Research and Treatment. 160(2). 261–267. 5 indexed citations

Rossi, Giovanni, Roberta Iadarola, Matteo Lambertini, et al.. (2015). The value of hormone serum concentration to predict the gonadotoxic effect of chemotherapy and the efficacy of LHRH analogs as a strategy to reduce treatment-related premature ovarian failure in breast cancer. Annals of Oncology. 26. vi8–vi8. 1 indexed citations

Lambertini, Matteo, Luca Boni, Andrea Michelotti, et al.. (2015). Long-term outcome results of the phase III PROMISE-GIM6 study evaluating the role of LHRH analog (LHRHa) during chemotherapy as a strategy to reduce ovarian failure in early breast cancer patients. Annals of Oncology. 26. vi1–vi1. 26 indexed citations

Giraudi, S., Matteo Lambertini, Paola Anserini, et al.. (2015). Prospective study of fertility preservation strategies in young early breast cancer patients: the PREFER (PREgnancy and FERtility) trial. Annals of Oncology. 26. vi10–vi10. 1 indexed citations

10.

Lambertini, Matteo, Luca Boni, Andrea Michelotti, et al.. (2015). Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival. JAMA. 314(24). 2632–2632. 146 indexed citations

11.

Sini, Valentina, Gianluigi Lunardi, Monica Turazza, et al.. (2014). Body mass index and circulating oestrone sulphate in women treated with adjuvant letrozole. British Journal of Cancer. 110(5). 1133–1138. 10 indexed citations

12.

Lambertini, Matteo, Luca Boni, Andrea Michelotti, et al.. (2014). Long-term outcome results of the phase III PROMISE-GIM6 study evaluating the role of LHRH analog (LHRHa) during chemotherapy (CT) as a strategy to reduce ovarian failure in early breast cancer (BC) patients.. Journal of Clinical Oncology. 32(26_suppl). 105–105. 10 indexed citations

13.

Levaggi, Alessia, Andrea De Maria, Béatrice Dozin, et al.. (2014). Incidence of hepatitis in patients with evidence of past or current hepatitis B or C during chemotherapy for early breast cancer.. PubMed. 34(7). 3715–20. 2 indexed citations

14.

Mastro, Lucia Del, Marcello Ceppi, Francesca Poggio, et al.. (2013). Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: Systematic review and meta-analysis of randomized trials. Cancer Treatment Reviews. 40(5). 675–683. 127 indexed citations

15.

Mastro, Lucia Del, Matteo Lambertini, Claudia Bighin, et al.. (2012). Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients. Expert Review of Anticancer Therapy. 12(11). 1391–1405. 19 indexed citations

16.

Lambertini, Matteo, Paolo Bruzzi, Alessia Levaggi, et al.. (2012). HM35 Role of temporary ovarian suppression obtained with GnRH analogue in reducing premature ovarian failure induced by chemotherapy in premenopausal cancer patients: a meta-analysis of randomized studies. The Breast. 21. S13–S13. 2 indexed citations

17.

Mastro, Lucia Del, S. Giraudi, Alessia Levaggi, & P. Pronzato. (2011). Medical approaches to preservation of fertility in female cancer patients. Expert Opinion on Pharmacotherapy. 12(3). 387–396. 25 indexed citations

18.

Mastro, Lucia Del, Luca Boni, Andrea Michelotti, et al.. (2011). Effect of the Gonadotropin-Releasing Hormone Analogue Triptorelin on the Occurrence of Chemotherapy-Induced Early Menopause in Premenopausal Women With Breast Cancer. JAMA. 306(3). 269–76. 259 indexed citations

19.

Mastro, Lucia Del, Alessia Levaggi, S. Giraudi, & P. Pronzato. (2010). Luteinising hormone releasing hormone agonists (LH-RHa) in premenopausal early breast cancer patients: Current role and future perspectives. Cancer Treatment Reviews. 37(3). 208–211. 15 indexed citations

20.

Giraudi, S., Paola Marroni, Luca Boni, et al.. (2009). Anti-Mullerian hormone (AMH) and ovarian function in young breast cancer (BC) women receiving adjuvant chemoterapy (CT). Journal of Clinical Oncology. 27(15_suppl). e11544–e11544. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact